[go: up one dir, main page]

DE60301277D1 - Pharmazeutische zubereitung enthaltend valaciclovir - Google Patents

Pharmazeutische zubereitung enthaltend valaciclovir

Info

Publication number
DE60301277D1
DE60301277D1 DE60301277T DE60301277T DE60301277D1 DE 60301277 D1 DE60301277 D1 DE 60301277D1 DE 60301277 T DE60301277 T DE 60301277T DE 60301277 T DE60301277 T DE 60301277T DE 60301277 D1 DE60301277 D1 DE 60301277D1
Authority
DE
Germany
Prior art keywords
pharmaceutical preparation
preparation containing
valaciclovir
containing valaciclovir
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60301277T
Other languages
English (en)
Other versions
DE60301277T2 (de
Inventor
Dr Lieb
Dr Loeffler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karl O Helm AG
Original Assignee
Karl O Helm AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karl O Helm AG filed Critical Karl O Helm AG
Application granted granted Critical
Publication of DE60301277D1 publication Critical patent/DE60301277D1/de
Publication of DE60301277T2 publication Critical patent/DE60301277T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60301277T 2003-12-09 2003-12-09 Pharmazeutische zubereitung enthaltend valaciclovir Expired - Lifetime DE60301277T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03028222A EP1541133B1 (de) 2003-12-09 2003-12-09 Pharmazeutische zubereitung enthaltend valaciclovir

Publications (2)

Publication Number Publication Date
DE60301277D1 true DE60301277D1 (de) 2005-09-15
DE60301277T2 DE60301277T2 (de) 2006-03-30

Family

ID=34486148

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60301277T Expired - Lifetime DE60301277T2 (de) 2003-12-09 2003-12-09 Pharmazeutische zubereitung enthaltend valaciclovir

Country Status (5)

Country Link
US (1) US20050123607A1 (de)
EP (1) EP1541133B1 (de)
AT (1) ATE301455T1 (de)
DE (1) DE60301277T2 (de)
ES (1) ES2246034T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007090595A1 (en) * 2006-02-06 2007-08-16 Fidia Pharmaceutici S.P.A. Solid formulations of valacyclovir hydrochloride
CN110693840A (zh) * 2019-09-19 2020-01-17 湖北科益药业股份有限公司 一种高利用度的盐酸伐昔洛韦分散片及其制备工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2705966B1 (fr) * 1993-06-04 1995-08-25 Dow Corning Sa Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
US6946465B2 (en) * 1999-02-02 2005-09-20 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CA2403831C (en) * 2001-02-27 2009-11-24 Rohm Gmbh & Co. Kg Coating and binding agent for pharmaceutical formulations having improved storage stability
EP1436295A4 (de) * 2001-09-07 2007-07-11 Teva Pharma Kristalline formen von valacyclovir-hydrochlorid
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic

Also Published As

Publication number Publication date
US20050123607A1 (en) 2005-06-09
EP1541133B1 (de) 2005-08-10
ES2246034T3 (es) 2006-02-01
DE60301277T2 (de) 2006-03-30
EP1541133A1 (de) 2005-06-15
ATE301455T1 (de) 2005-08-15

Similar Documents

Publication Publication Date Title
ATE307571T1 (de) Pharmazeutische formulierung enthaltend bicalutamid
DE50212273D1 (de) Pharmazeutische salze von 1-phenyl-3-dimethylamino-propan-verbindungen
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
ATE317260T1 (de) Pharmazeutische formulierungen mit platinderivaten
EE200200357A (et) Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
DE602004024375D1 (de) Carboxamidderivate
NO20033384D0 (no) Farmasöytisk formulering
DE60210552D1 (de) Prozess zur Herstellung einer festen pharmazeutischen Zubereitung welche einen schwerlöslichen Wirkstoff enthält
SE0302192D0 (sv) Novel compounds
DE602005007339D1 (de) Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol
ATE320807T1 (de) Pharmazeutische zusammensetzungen enthaltend tegaserod
EE200300537A (et) Meetod madalaannuselise farmatseutilise kompositsiooni tootmiseks
NO20035627D0 (no) Farmasöytisk formulering
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
GB0109122D0 (en) Novel compounds
DE60211183D1 (de) Pharmazeutische zusammensetzung enthaltend lumiracoxib
SE0102440D0 (sv) New compound
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
ATE507831T1 (de) Melatonin enthaltende pharmazeutische formulierung
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
SE0202693D0 (sv) Compounds
ATE301455T1 (de) Pharmazeutische zubereitung enthaltend valaciclovir
SE0202692D0 (sv) Compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition